Asan Medical Center ( Site 5901) — Seoul

Public research footprint of Asan Medical Center ( Site 5901), compiled from the ClinicalTrials.gov public registry.

2,687

Registered studies

817

Active

435

Recruiting now

1,299

Completed

288

Stopped or withdrawn

Most-studied conditions

Breast Cancer · NSCLC (Advanced Non-small Cell Lung Cancer) · Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer · Mature B-Cell Non-Hodgkin Lymphoma

Recently updated registry entries

NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT06790693 — A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and… (Recruiting)
NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Asan Medical Center ( Site 5901)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.